CytomX Therapeutics Inc (CTMX)
4.489
-0.64
(-12.49%)
USD |
NASDAQ |
May 02, 16:00
4.69
+0.20
(+4.48%)
After-Hours: 07:33
CytomX Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Ocular Therapeutix Inc | 90.64% |
Bristol-Myers Squibb Co | 75.29% |
ACADIA Pharmaceuticals Inc | 92.26% |
Cytokinetics Inc | -4.98K% |
Calidi Biotherapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -0.25% |
Profit Margin (Quarterly) | 3.15% |
Operating Margin (Quarterly) | -2.28% |
Return on Net Operating Assets | -1.94% |